Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neospastil vs Ketorolac for Post-surgical Pain
NCT05607641Phase 3Completed
- Sponsor
- Darnitsa
- Start
- Jul 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Neospastil in postoperative pain, sponsored by Darnitsa. Started Jul 2021; status: completed.
02
Drugs
Neospastil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05607641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05607641.